ZEB2 and breast carcinoma: SIP1 is frequently upregulated in a variety of human cancers, including pancreatic cancer [33], breast cancer [34], gastric cancer [35], renal caner [36], non-small cell lung cancer [37], hepatocellular carcinoma [38], and ICC [39].